1Hooton TM, Levy SB. Antimicrobial resistance: a plan of action for community practice [J]. Am Fam Physician, 2001, 63(6): 1087-1098. 被引量：1
2Paradisi F, Corti G, Messeri D. Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics [J]. Med Clin North Am, 2001, 85(1): 1-17. 被引量：1
3Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical eharacterlstics of community acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children [J]. Pedlatr Infect Dis J, 2002, 21(10): 910-917. 被引量：1
4Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children [J]. Pediatr Infect Dis J, 2002, 21(6) : 530-534. 被引量：1
5Kaplan SL. Treatment of communlty-associated methicillin-resistant Staphylococcus aureus infections [J]. Pediatr Infect Dis J, 2005, 24(5): 457-458. 被引量：1
6Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States [J]. N Engl J Med, 2000, 343(26): 1917-1924. 被引量：1
8Brueggemann AB, Coffman SL, Rhomberg P, et al. Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995 [J]. Antimicrob Agents Chemother, 2002, 46 (3) : 680-688. 被引量：1
9Dowell SF, Butler JC, Giebink GS. Acute otitis media: management and surveillance in an era of pneumococcal resistance. Drug-Resistant Streptococcus Pneumoniae Therapeutic Working Group [J]. NursePract, 1999, 24(10 Suppl): 1-9, quiz 15-16. 被引量：1
10Jasir A, Tanna A, Noorani A, et al. High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study [J]. J Clin Microbiol, 2000, 38(6): 2103-2107. 被引量：1
